Cargando…

Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene?

INTRODUCTION: Charcot–Marie–Tooth neuropathy (CMT) is a genetically heterogeneous group of peripheral neuropathies. In addition to the classical clinical phenotype, additional features can occur. METHODS: We studied a wide range of additional features in a cohort of 49 genetically confirmed CMT pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Werheid, Friederike, Azzedine, Hamid, Zwerenz, Eva, Bozkurt, Ahmet, Moeller, Marcus J., Lin, Lilian, Mull, Michael, Häusler, Martin, Schulz, Jörg B., Weis, Joachim, Claeys, Kristl G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782242/
https://www.ncbi.nlm.nih.gov/pubmed/27088055
http://dx.doi.org/10.1002/brb3.451
_version_ 1782419914368221184
author Werheid, Friederike
Azzedine, Hamid
Zwerenz, Eva
Bozkurt, Ahmet
Moeller, Marcus J.
Lin, Lilian
Mull, Michael
Häusler, Martin
Schulz, Jörg B.
Weis, Joachim
Claeys, Kristl G.
author_facet Werheid, Friederike
Azzedine, Hamid
Zwerenz, Eva
Bozkurt, Ahmet
Moeller, Marcus J.
Lin, Lilian
Mull, Michael
Häusler, Martin
Schulz, Jörg B.
Weis, Joachim
Claeys, Kristl G.
author_sort Werheid, Friederike
collection PubMed
description INTRODUCTION: Charcot–Marie–Tooth neuropathy (CMT) is a genetically heterogeneous group of peripheral neuropathies. In addition to the classical clinical phenotype, additional features can occur. METHODS: We studied a wide range of additional features in a cohort of 49 genetically confirmed CMT patients and performed a systematic literature revision. RESULTS: Patients harbored a PMP22 gene alteration (n = 28) or a mutation in MPZ (n = 11), GJB1 (n = 4), LITAF (n = 2), MFN2 (n = 2), INF2 (n = 1), NEFL (n = 1). We identified four novel mutations (3 MPZ, 1 GJB1). A total of 88% presented at least one additional feature. In MPZ patients, we detected hypertrophic nerve roots in 3/4 cases that underwent spinal MRI, and pupillary abnormalities in 27%. In our cohort, restless legs syndrome (RLS) was present in 18%. We describe for the first time RLS associated with LITAF or MFN2 and predominant upper limb involvement with LITAF. Cold‐induced hand cramps occurred in 10% (PMP22,MPZ,MFN2), and autonomous nervous system involvement in 18% (PMP22,MPZ, LITAF,MFN2). RLS and respiratory insufficiency were mostly associated with severe neuropathy, and pupillary abnormalities with mild to moderate neuropathy. CONCLUSIONS: In CMT patients, additional features occur frequently. Some of them might be helpful in orienting genetic diagnosis. Our data broaden the clinical spectrum and genotype–phenotype associations with CMT.
format Online
Article
Text
id pubmed-4782242
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-47822422016-04-15 Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene? Werheid, Friederike Azzedine, Hamid Zwerenz, Eva Bozkurt, Ahmet Moeller, Marcus J. Lin, Lilian Mull, Michael Häusler, Martin Schulz, Jörg B. Weis, Joachim Claeys, Kristl G. Brain Behav Original Research INTRODUCTION: Charcot–Marie–Tooth neuropathy (CMT) is a genetically heterogeneous group of peripheral neuropathies. In addition to the classical clinical phenotype, additional features can occur. METHODS: We studied a wide range of additional features in a cohort of 49 genetically confirmed CMT patients and performed a systematic literature revision. RESULTS: Patients harbored a PMP22 gene alteration (n = 28) or a mutation in MPZ (n = 11), GJB1 (n = 4), LITAF (n = 2), MFN2 (n = 2), INF2 (n = 1), NEFL (n = 1). We identified four novel mutations (3 MPZ, 1 GJB1). A total of 88% presented at least one additional feature. In MPZ patients, we detected hypertrophic nerve roots in 3/4 cases that underwent spinal MRI, and pupillary abnormalities in 27%. In our cohort, restless legs syndrome (RLS) was present in 18%. We describe for the first time RLS associated with LITAF or MFN2 and predominant upper limb involvement with LITAF. Cold‐induced hand cramps occurred in 10% (PMP22,MPZ,MFN2), and autonomous nervous system involvement in 18% (PMP22,MPZ, LITAF,MFN2). RLS and respiratory insufficiency were mostly associated with severe neuropathy, and pupillary abnormalities with mild to moderate neuropathy. CONCLUSIONS: In CMT patients, additional features occur frequently. Some of them might be helpful in orienting genetic diagnosis. Our data broaden the clinical spectrum and genotype–phenotype associations with CMT. John Wiley and Sons Inc. 2016-03-04 /pmc/articles/PMC4782242/ /pubmed/27088055 http://dx.doi.org/10.1002/brb3.451 Text en © 2016 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Werheid, Friederike
Azzedine, Hamid
Zwerenz, Eva
Bozkurt, Ahmet
Moeller, Marcus J.
Lin, Lilian
Mull, Michael
Häusler, Martin
Schulz, Jörg B.
Weis, Joachim
Claeys, Kristl G.
Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene?
title Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene?
title_full Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene?
title_fullStr Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene?
title_full_unstemmed Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene?
title_short Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene?
title_sort underestimated associated features in cmt neuropathies: clinical indicators for the causative gene?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782242/
https://www.ncbi.nlm.nih.gov/pubmed/27088055
http://dx.doi.org/10.1002/brb3.451
work_keys_str_mv AT werheidfriederike underestimatedassociatedfeaturesincmtneuropathiesclinicalindicatorsforthecausativegene
AT azzedinehamid underestimatedassociatedfeaturesincmtneuropathiesclinicalindicatorsforthecausativegene
AT zwerenzeva underestimatedassociatedfeaturesincmtneuropathiesclinicalindicatorsforthecausativegene
AT bozkurtahmet underestimatedassociatedfeaturesincmtneuropathiesclinicalindicatorsforthecausativegene
AT moellermarcusj underestimatedassociatedfeaturesincmtneuropathiesclinicalindicatorsforthecausativegene
AT linlilian underestimatedassociatedfeaturesincmtneuropathiesclinicalindicatorsforthecausativegene
AT mullmichael underestimatedassociatedfeaturesincmtneuropathiesclinicalindicatorsforthecausativegene
AT hauslermartin underestimatedassociatedfeaturesincmtneuropathiesclinicalindicatorsforthecausativegene
AT schulzjorgb underestimatedassociatedfeaturesincmtneuropathiesclinicalindicatorsforthecausativegene
AT weisjoachim underestimatedassociatedfeaturesincmtneuropathiesclinicalindicatorsforthecausativegene
AT claeyskristlg underestimatedassociatedfeaturesincmtneuropathiesclinicalindicatorsforthecausativegene